Grothey A - Search Results

1

Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE).

Grothey A, Sugrue MM, Purdie DM, Dong W, Sargent D, Hedrick E, Kozloff M. Grothey A, et al. J Clin Oncol. 2008 Nov 20;26(33):5326-34. doi: 10.1200/JCO.2008.16.3212. Epub 2008 Oct 14. J Clin Oncol. 2008. PMID: 18854571

2

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.

Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Grothey A, et al. J Clin Oncol. 2004 Apr 1;22(7):1209-14. doi: 10.1200/JCO.2004.11.037. J Clin Oncol. 2004. PMID: 15051767

3

Oxaliplatin plus oral fluoropyrimidines in colorectal cancer.

Grothey A, Goetz MP. Grothey A, et al. Clin Colorectal Cancer. 2004 Jun;4 Suppl 1:S37-42. doi: 10.3816/ccc.2004.s.006. Clin Colorectal Cancer. 2004. PMID: 15212704 Review.

4

Developments in combination chemotherapy for colorectal cancer.

Goetz MP, Grothey A. Goetz MP, et al. Among authors: grothey a. Expert Rev Anticancer Ther. 2004 Aug;4(4):627-37. doi: 10.1586/14737140.4.4.627. Expert Rev Anticancer Ther. 2004. PMID: 15270666 Review.

5

A review of oxaliplatin and its clinical use in colorectal cancer.

Grothey A, Goldberg RM. Grothey A, et al. Expert Opin Pharmacother. 2004 Oct;5(10):2159-70. doi: 10.1517/14656566.5.10.2159. Expert Opin Pharmacother. 2004. PMID: 15461551 Review.

6

Clinical management of oxaliplatin-associated neurotoxicity.

Grothey A. Grothey A. Clin Colorectal Cancer. 2005 Apr;5 Suppl 1:S38-46. doi: 10.3816/ccc.2005.s.006. Clin Colorectal Cancer. 2005. PMID: 15871765 Review.

7

FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.

Grothey A, Sargent DJ. Grothey A, et al. J Clin Oncol. 2005 May 20;23(15):3311-3. doi: 10.1200/JCO.2005.11.691. J Clin Oncol. 2005. PMID: 15908645 No abstract available.

8

Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab.

Ellis LM, Curley SA, Grothey A. Ellis LM, et al. Among authors: grothey a. J Clin Oncol. 2005 Aug 1;23(22):4853-5. doi: 10.1200/JCO.2005.23.754. J Clin Oncol. 2005. PMID: 16051943 No abstract available.

9

Clinical trial designs for prospective validation of biomarkers.

Mandrekar SJ, Grothey A, Goetz MP, Sargent DJ. Mandrekar SJ, et al. Among authors: grothey a. Am J Pharmacogenomics. 2005;5(5):317-25. doi: 10.2165/00129785-200505050-00004. Am J Pharmacogenomics. 2005. PMID: 16196501

10

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, Blanke CD, Kerr D, Green E, Wolmark N, Andre T, Goldberg RM, De Gramont A. Sargent DJ, et al. Among authors: grothey a. J Clin Oncol. 2005 Dec 1;23(34):8664-70. doi: 10.1200/JCO.2005.01.6071. Epub 2005 Oct 31. J Clin Oncol. 2005. PMID: 16260700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters